Senseonics (SENS) Stock: Buy, Sell, or Hold?
SENS - Senseonics Holdings, Inc.
$7.97
-0.24 (-2.92%)
▼
5d:
-1.6%
30d:
-20.78%
90d:
+63.66%
HOLD
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When SENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SENS is currently trading at $7.97, which is considered oversold relative to its 30-day fair value range of $8.50 to $10.06.
Technical Outlook: Technically, SENS is in a strong uptrend. The price is currently testing key support at $7.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SENS scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.67 (+71.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SENS is in a strong uptrend. The price is currently testing key support at $7.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SENS scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (1th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.67 (+71.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.50 -
$10.06
Company Quality Score
56/100
(HOLD)
Options IV Signal
1th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
95.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 1th percentile)
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.5% below Wall St target ($13.67)
- CAUTION: Bottoming setup, but lagging the sector by 13% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$8.50 -
$10.06
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.76
(9.5%)
Support & Resistance Levels
Support Level
$7.75
Resistance Level
$9.35
Current Trend
Strong Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.08
Wall Street Target
$13.67
(+71.5%)
Revenue Growth (YoY)
117.8%
Profit Margin
-225.3%
Share & Embed Analysis
Last updated: October 22, 2026 6:36 AM ET
Data refreshes hourly during market hours. Next update: 7:36 AM
Data refreshes hourly during market hours. Next update: 7:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SENS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 53 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
CATX
Perspective Therapeutics… |
STRONG BUY
14 analysts |
$12 | 60 HOLD |
